Hey ghmm, any thoughts on FOLD? It seems to be similarnto BMRN. Although BMRN is more of mature company. Glaxo continues to buy shares of FOLD. They also have decent institutional ownership. Glaxo paid a premium for shares, perhaps to hedge in case good news comes out and the price takes off. I think news on their trial will be out soon. Tia
"Don't worry about the world coming to an end today. It's already tomorrow in Australia"